HealthQuill Drugs
AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key goal in late-stage trials, the company announced.
Drugs Medical Pharma

AbbVie’s late-stage experimental drug reduces menstrual migraine days

HQ Team September 11, 2026: AbbVie Inc.’s experimental drug has reduced the number of migraine days during the menstrual period, meeting a key.

Read More
A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a major reversal of previous progress toward the elimination of the disease, according to an editorial in the International Journal of Infectious Diseases.
Drugs Health Opinion

Bangladesh’s measles outbreak an ‘early warning signal’: IJID says

HQ Team September 11, 2026: A measles outbreak in the South Asian nation of Bangladesh, which has killed nearly 1,000 people, is a.

Read More
A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses high-intensity sound waves to break down targeted diseased tissue without incisions, heat, or trauma, enabling the body to heal itself naturally.
Drugs Medical Pharma

US-based start-up developing medical device to replace surgical incision

HQ Team September 10, 2026: A team of neurosurgeons, medical robotics specialists, and advanced energy systems engineers is building  a device that uses.

Read More
Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced.
Drugs Medical Pharma

Novartis’s neuromuscular experimental drug fails to meet targets

HQ Team September 9, 2026: Novartis AG’s experimental drug to treat a neuromuscular disease failed to meet its target, the company announced. The.

Read More
The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization, has released 70,000 doses of its experimental Ervebo vaccine to the Democratic Republic of the Congo to assess its effectiveness in combating the Bundibugyo Ebola virus disease.
Drugs Health Research

ICG ships vaccines to Congo to test feasibility in Bundibugyo Ebola

HQ Team August 21, 2026: The International Coordinating Group on Vaccine Provision (ICG), a coalition of health groups including the World Health Organization,.

Read More
An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo at an “unprecedented speed” until every transmission chain is found and broken, Dr Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, said.
Drugs Health Pharma

World still ‘playing catch-up’ with Ebola virus epidemic in Congo: WHO chief

HQ Team August 19, 2026: An epidemic caused by the Bundibugyo virus will continue to spread in the central African country of Congo.

Read More
AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination therapy failed to outperform standard treatments for advanced non-small cell lung cancer.
Drugs Health Pharma

AstraZeneca ends late-stage trial of drug to treat non-small cell cancer

HQ Team August 17, 2026: AstraZeneca has stopped an end-phase trial for its experimental lung cancer drug, volrustomig, after data showed the combination.

Read More
An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325 people, becoming the deadliest in the central African country of the Democratic Republic of Congo.
Drugs Health Medical

Ebola virus becomes deadliest outbreak in Congo, still ‘moving fast’

HQ Team August 17, 2026: An outbreak of the Bundibugyo species of Ebola, which has no approved vaccines or treatments, has killed 2,325.

Read More
Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of the Covid-19 virus to contribute to their persistence and recurrence of the infection, a study finds.
Drugs

1 in 6 people rate bad primary care as “fine”, reveals 18-country survey

HQ Team July 24, 2026: Nearly one in six people surveyed across 18 countries rated a textbook case of poor primary care, including.

Read More
nasal spray
Drugs

Eli Lilly spent $3.8 billion on psychedelics. Here’s the reason why

HQ Team July 23, 2026: Eli Lilly, the pharma company behind weight-loss blockbusters Mounjaro and Zepbound recently agreed to buy AtaiBeckley, a psychedelic.

Read More